In summary, through a multipronged experimental approach, we identified an important mechanism in the progression of CRC: cholesterol-mediated inhibition of RORα/γ sustains c-myc stability and hence promotes CRC cell growth and metastasis. Here, RORA is linked to colorectal carcinoma.